Subsidiary Guarantors (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	May 02, 2014	Apr. 26, 2013	May 02, 2014	Apr. 26, 2013	Jan. 31, 2014	Oct. 25, 2013	Jan. 25, 2013	Oct. 26, 2012
Condensed Consolidating Statement of Income
Net sales	$ 929,730	$ 1,360,435	$ 1,769,042	$ 2,510,312
Cost of sales	651,592	909,179	1,255,770	1,682,328
Product development, selling and administrative expenses	154,534	172,953	307,563	330,234
Other (income) expense, net	(2,138)	(330)	(5,278)	(2,035)
Operating income	125,742	278,633	210,987	499,785
Income from continuing operations before income taxes	111,894	263,448	183,319	469,447
Provision (benefit) for income taxes	37,943	81,669	60,507	145,529
Income from continuing operations	73,951	181,779	122,812	323,918
Comprehensive income	103,186	169,969	105,589	315,336
Current assets:
Cash and cash equivalents	385,790	234,875	385,790	234,875
Accounts receivable, net	917,502		917,502			1,083,663
Inventories	1,128,891		1,128,891			1,139,744
Other current assets	201,838		201,838			193,328
Total current assets	2,634,021		2,634,021			2,822,444
Property, plant and equipment, net	893,649		893,649			912,642
Other assets:
Other intangible assets, net	322,701		322,701			331,812
Goodwill	1,492,689		1,492,689			1,480,519
Deferred income taxes	39,746		39,746			41,532
Other non-current assets	194,928		194,928			200,633
Total other assets	2,050,064		2,050,064			2,054,496
Total assets	5,577,734		5,577,734			5,789,582
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	58,089		58,089			58,669
Trade accounts payable	335,319		335,319			388,119
Employee compensation and benefits	111,713		111,713			130,555
Advance payments and progress billings	403,518		403,518			399,768
Accrued warranties	73,602	83,691	73,602	83,691	77,804	85,732	87,427	100,646
Other accrued liabilities	225,953		225,953			286,063
Current liabilities of discontinued operations	11,684		11,684			11,684
Total current liabilities	1,219,878		1,219,878			1,360,590
Long-term obligations	1,231,572		1,231,572			1,256,927
Other liabilities:
Liabilities for postretirement benefits	19,944		19,944			20,723
Accrued pension costs	139,196		139,196			149,805
Other non-current liabilities	152,328		152,328			143,168
Total other liabilities	311,468		311,468			313,696
Shareholders’ equity	2,814,816		2,814,816			2,858,369
Total liabilities and shareholders’ equity	5,577,734		5,577,734			5,789,582
Operating Activities:
Net cash provided by operating activities of continuing operations			206,675	93,275
Net cash used by operating activities of discontinued operations			(115)	(2,372)
Net cash provided by operating activities			206,560	90,903
Investing Activities:
Property, plant and equipment acquired	(17,649)	(32,413)	(44,304)	(87,001)
Proceeds from sale of property, plant and equipment			4,205	2,187
Other investing activities, net			(66)	(70)
Net cash used by investing activities			(40,165)	(84,884)
Financing Activities:
Common stock issued			6,581	5,227
Excess tax (expense) benefit from share-based compensation awards			(432)	1,701
Dividends paid			(35,374)	(37,130)
Repayments of term loan			(25,000)	(25,000)
Changes in short and other long-term obligations, net			(1,262)	22,216
Treasury stock purchased			(129,504)	0
Net cash used by financing activities			(184,991)	(32,986)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			(1,323)	(2,031)
Decrease in Cash and Cash Equivalents			(19,919)	(28,998)
Cash and Cash Equivalents at Beginning of Period			405,709	263,873
Cash and Cash Equivalents at End of Period	385,790	234,875	385,790	234,875
Parent Company
Condensed Consolidating Statement of Income
Net sales	0	0	0	0
Cost of sales	0	0	0	0
Product development, selling and administrative expenses	14,154	16,608	28,823	29,410
Other (income) expense, net	0	0	(473)	0
Operating income	(14,154)	(16,608)	(28,350)	(29,410)
Intercompany items	15,503	26,889	32,781	58,009
Interest (expense) income, net	(15,836)	(10,355)	(31,881)	(32,925)
Income from continuing operations before income taxes	(14,487)	(74)	(27,450)	(4,326)
Provision (benefit) for income taxes	(4,878)	(11,361)	(9,932)	(20,637)
Equity in income of subsidiaries	83,560	170,492	140,330	307,607
Income from continuing operations	73,951	181,779	122,812	323,918
Comprehensive income	103,186	169,969	105,589	315,336
Current assets:
Cash and cash equivalents	111,157	169	111,157	169
Accounts receivable, net	0		0			0
Inventories	0		0			0
Other current assets	70,414		70,414			68,792
Total current assets	181,571		181,571			191,693
Property, plant and equipment, net	18,623		18,623			18,081
Other assets:
Other intangible assets, net	0		0			0
Goodwill	0		0			0
Deferred income taxes	(30,530)		(30,530)			(49,393)
Other non-current assets	4,113,371		4,113,371			4,168,916
Total other assets	4,082,841		4,082,841			4,119,523
Total assets	4,283,035		4,283,035			4,329,297
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	50,000		50,000			50,000
Trade accounts payable	967		967			2,565
Employee compensation and benefits	8,857		8,857			10,080
Advance payments and progress billings	0		0			0
Accrued warranties	0		0			0
Other accrued liabilities	43,548		43,548			24,545
Current liabilities of discontinued operations	0		0			0
Total current liabilities	103,372		103,372			87,190
Long-term obligations	1,231,556		1,231,556			1,256,164
Other liabilities:
Liabilities for postretirement benefits	19,091		19,091			19,881
Accrued pension costs	126,575		126,575			136,886
Other non-current liabilities	(12,375)		(12,375)			(29,193)
Total other liabilities	133,291		133,291			127,574
Shareholders’ equity	2,814,816		2,814,816			2,858,369
Total liabilities and shareholders’ equity	4,283,035		4,283,035			4,329,297
Operating Activities:
Net cash provided by operating activities of continuing operations			174,009	26,790
Net cash used by operating activities of discontinued operations			0	0
Net cash provided by operating activities			174,009	26,790
Investing Activities:
Property, plant and equipment acquired			(1,958)	(2,808)
Proceeds from sale of property, plant and equipment			0	0
Other investing activities, net			(66)	(70)
Net cash used by investing activities			(2,024)	(2,878)
Financing Activities:
Common stock issued			6,581	5,227
Excess tax (expense) benefit from share-based compensation awards			(432)	1,701
Dividends paid			(35,374)	(37,130)
Repayments of term loan			(25,000)	(25,000)
Changes in short and other long-term obligations, net			0	28,000
Treasury stock purchased			(129,504)
Net cash used by financing activities			(183,729)	(27,202)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			0	0
Decrease in Cash and Cash Equivalents			(11,744)	(3,290)
Cash and Cash Equivalents at Beginning of Period			122,901	3,459
Cash and Cash Equivalents at End of Period	111,157	169	111,157	169
Subsidiary Guarantors
Condensed Consolidating Statement of Income
Net sales	500,309	816,797	980,981	1,417,753
Cost of sales	370,922	578,803	733,989	989,446
Product development, selling and administrative expenses	66,670	79,826	134,505	153,943
Other (income) expense, net	4,203	6,785	6,152	15,961
Operating income	58,514	151,383	106,335	258,403
Intercompany items	(25,742)	(23,967)	(45,728)	(43,815)
Interest (expense) income, net	1,711	477	3,596	574
Income from continuing operations before income taxes	34,483	127,893	64,203	215,162
Provision (benefit) for income taxes	29,852	66,819	56,220	123,865
Equity in income of subsidiaries	47,954	106,652	80,967	196,610
Income from continuing operations	52,585	167,726	88,950	287,907
Comprehensive income	52,820	165,839	87,650	284,297
Current assets:
Cash and cash equivalents	9,456	3,725	9,456	3,725
Accounts receivable, net	367,991		367,991			410,928
Inventories	474,587		474,587			456,345
Other current assets	8,767		8,767			16,957
Total current assets	860,801		860,801			904,591
Property, plant and equipment, net	360,075		360,075			375,026
Other assets:
Other intangible assets, net	238,623		238,623			247,200
Goodwill	453,375		453,375			454,199
Deferred income taxes	0		0			0
Other non-current assets	1,925,690		1,925,690			2,065,239
Total other assets	2,617,688		2,617,688			2,766,638
Total assets	3,838,564		3,838,564			4,046,255
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	0		0			449
Trade accounts payable	176,382		176,382			165,691
Employee compensation and benefits	53,288		53,288			52,260
Advance payments and progress billings	137,598		137,598			144,853
Accrued warranties	24,339		24,339			30,111
Other accrued liabilities	48,943		48,943			54,285
Current liabilities of discontinued operations	11,684		11,684			11,684
Total current liabilities	452,234		452,234			459,333
Long-term obligations	0		0			763
Other liabilities:
Liabilities for postretirement benefits	853		853			842
Accrued pension costs	5,361		5,361			5,685
Other non-current liabilities	8,084		8,084			7,851
Total other liabilities	14,298		14,298			14,378
Shareholders’ equity	3,372,032		3,372,032			3,571,781
Total liabilities and shareholders’ equity	3,838,564		3,838,564			4,046,255
Operating Activities:
Net cash provided by operating activities of continuing operations			56	20,072
Net cash used by operating activities of discontinued operations			(115)	(2,372)
Net cash provided by operating activities			(59)	17,700
Investing Activities:
Property, plant and equipment acquired			(12,344)	(21,815)
Proceeds from sale of property, plant and equipment			2,710	1,421
Other investing activities, net			0	0
Net cash used by investing activities			(9,634)	(20,394)
Financing Activities:
Common stock issued			0	0
Excess tax (expense) benefit from share-based compensation awards			0	0
Dividends paid			0	0
Repayments of term loan			0	0
Changes in short and other long-term obligations, net			(1,212)	(209)
Treasury stock purchased			0
Net cash used by financing activities			(1,212)	(209)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			0	0
Decrease in Cash and Cash Equivalents			(10,905)	(2,903)
Cash and Cash Equivalents at Beginning of Period			20,361	6,628
Cash and Cash Equivalents at End of Period	9,456	3,725	9,456	3,725
Non-Guarantor Subsidiaries
Condensed Consolidating Statement of Income
Net sales	630,602	898,483	1,233,367	1,776,004
Cost of sales	443,475	622,410	889,314	1,243,530
Product development, selling and administrative expenses	73,710	76,519	144,235	146,881
Other (income) expense, net	(6,341)	(7,115)	(10,957)	(17,996)
Operating income	119,758	206,669	210,775	403,589
Intercompany items	(2,934)	(26,876)	(12,005)	(62,533)
Interest (expense) income, net	277	(5,307)	617	2,013
Income from continuing operations before income taxes	117,101	174,486	199,387	343,069
Provision (benefit) for income taxes	12,948	26,211	14,198	42,301
Equity in income of subsidiaries	0	0	0	0
Income from continuing operations	104,153	148,275	185,189	300,768
Comprehensive income	128,297	134,239	161,629	283,239
Current assets:
Cash and cash equivalents	265,177	230,981	265,177	230,981
Accounts receivable, net	565,940		565,940			679,183
Inventories	761,425		761,425			813,182
Other current assets	122,642		122,642			107,564
Total current assets	1,715,184		1,715,184			1,862,376
Property, plant and equipment, net	514,951		514,951			519,535
Other assets:
Other intangible assets, net	84,078		84,078			84,612
Goodwill	1,039,314		1,039,314			1,026,320
Deferred income taxes	70,276		70,276			90,925
Other non-current assets	2,681,037		2,681,037			3,968,205
Total other assets	3,874,705		3,874,705			5,170,062
Total assets	6,104,840		6,104,840			7,551,973
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	8,089		8,089			8,220
Trade accounts payable	157,970		157,970			219,863
Employee compensation and benefits	49,568		49,568			68,215
Advance payments and progress billings	285,484		285,484			269,628
Accrued warranties	49,263		49,263			55,621
Other accrued liabilities	140,852		140,852			211,074
Current liabilities of discontinued operations	0		0			0
Total current liabilities	691,226		691,226			832,621
Long-term obligations	16		16			0
Other liabilities:
Liabilities for postretirement benefits	0		0			0
Accrued pension costs	7,260		7,260			7,234
Other non-current liabilities	156,619		156,619			164,510
Total other liabilities	163,879		163,879			171,744
Shareholders’ equity	5,249,719		5,249,719			6,547,608
Total liabilities and shareholders’ equity	6,104,840		6,104,840			7,551,973
Operating Activities:
Net cash provided by operating activities of continuing operations			32,610	46,413
Net cash used by operating activities of discontinued operations			0	0
Net cash provided by operating activities			32,610	46,413
Investing Activities:
Property, plant and equipment acquired			(30,002)	(62,378)
Proceeds from sale of property, plant and equipment			1,495	766
Other investing activities, net			0	0
Net cash used by investing activities			(28,507)	(61,612)
Financing Activities:
Common stock issued			0	0
Excess tax (expense) benefit from share-based compensation awards			0	0
Dividends paid			0	0
Repayments of term loan			0	0
Changes in short and other long-term obligations, net			(50)	(5,575)
Treasury stock purchased			0
Net cash used by financing activities			(50)	(5,575)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			(1,323)	(2,031)
Decrease in Cash and Cash Equivalents			2,730	(22,805)
Cash and Cash Equivalents at Beginning of Period			262,447	253,786
Cash and Cash Equivalents at End of Period	265,177	230,981	265,177	230,981
Eliminations
Condensed Consolidating Statement of Income
Net sales	(201,181)	(354,845)	(445,306)	(683,445)
Cost of sales	(162,805)	(292,034)	(367,533)	(550,648)
Product development, selling and administrative expenses	0	0	0	0
Other (income) expense, net	0	0	0	0
Operating income	(38,376)	(62,811)	(77,773)	(132,797)
Intercompany items	13,173	23,954	24,952	48,339
Interest (expense) income, net	0	0	0	0
Income from continuing operations before income taxes	(25,203)	(38,857)	(52,821)	(84,458)
Provision (benefit) for income taxes	21	0	21	0
Equity in income of subsidiaries	(131,514)	(277,144)	(221,297)	(504,217)
Income from continuing operations	(156,738)	(316,001)	(274,139)	(588,675)
Comprehensive income	(181,117)	(300,078)	(249,279)	(567,536)
Current assets:
Cash and cash equivalents	0		0
Accounts receivable, net	(16,429)		(16,429)			(6,448)
Inventories	(107,121)		(107,121)			(129,783)
Other current assets	15		15			15
Total current assets	(123,535)		(123,535)			(136,216)
Property, plant and equipment, net	0		0			0
Other assets:
Other intangible assets, net	0		0			0
Goodwill	0		0			0
Deferred income taxes	0		0			0
Other non-current assets	(8,525,170)		(8,525,170)			(10,001,727)
Total other assets	(8,525,170)		(8,525,170)			(10,001,727)
Total assets	(8,648,705)		(8,648,705)			(10,137,943)
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	0		0			0
Trade accounts payable	0		0			0
Employee compensation and benefits	0		0			0
Advance payments and progress billings	(19,564)		(19,564)			(14,713)
Accrued warranties	0		0			0
Other accrued liabilities	(7,390)		(7,390)			(3,841)
Current liabilities of discontinued operations	0		0			0
Total current liabilities	(26,954)		(26,954)			(18,554)
Long-term obligations	0		0			0
Other liabilities:
Liabilities for postretirement benefits	0		0			0
Accrued pension costs	0		0			0
Other non-current liabilities	0		0			0
Total other liabilities	0		0			0
Shareholders’ equity	(8,621,751)		(8,621,751)			(10,119,389)
Total liabilities and shareholders’ equity	(8,648,705)		(8,648,705)			(10,137,943)
Financing Activities:
Cash and Cash Equivalents at Beginning of Period			0
Cash and Cash Equivalents at End of Period	0		0
Consolidated
Condensed Consolidating Statement of Income
Net sales	929,730	1,360,435	1,769,042	2,510,312
Cost of sales	651,592	909,179	1,255,770	1,682,328
Product development, selling and administrative expenses	154,534	172,953	307,563	330,234
Other (income) expense, net	(2,138)	(330)	(5,278)	(2,035)
Operating income	125,742	278,633	210,987	499,785
Intercompany items	0	0	0	0
Interest (expense) income, net	(13,848)	(15,185)	(27,668)	(30,338)
Income from continuing operations before income taxes	111,894	263,448	183,319	469,447
Provision (benefit) for income taxes	37,943	81,669	60,507	145,529
Equity in income of subsidiaries	0	0	0	0
Income from continuing operations	73,951	181,779	122,812	323,918
Comprehensive income	103,186	169,969	105,589	315,336
Current assets:
Cash and cash equivalents	385,790	234,875	385,790	234,875
Accounts receivable, net	917,502		917,502			1,083,663
Inventories	1,128,891		1,128,891			1,139,744
Other current assets	201,838		201,838			193,328
Total current assets	2,634,021		2,634,021			2,822,444
Property, plant and equipment, net	893,649		893,649			912,642
Other assets:
Other intangible assets, net	322,701		322,701			331,812
Goodwill	1,492,689		1,492,689			1,480,519
Deferred income taxes	39,746		39,746			41,532
Other non-current assets	194,928		194,928			200,633
Total other assets	2,050,064		2,050,064			2,054,496
Total assets	5,577,734		5,577,734			5,789,582
Current liabilities:
Short-term notes payable, including current portion of long-term obligations	58,089		58,089			58,669
Trade accounts payable	335,319		335,319			388,119
Employee compensation and benefits	111,713		111,713			130,555
Advance payments and progress billings	403,518		403,518			399,768
Accrued warranties	73,602		73,602			85,732
Other accrued liabilities	225,953		225,953			286,063
Current liabilities of discontinued operations	11,684		11,684			11,684
Total current liabilities	1,219,878		1,219,878			1,360,590
Long-term obligations	1,231,572		1,231,572			1,256,927
Other liabilities:
Liabilities for postretirement benefits	19,944		19,944			20,723
Accrued pension costs	139,196		139,196			149,805
Other non-current liabilities	152,328		152,328			143,168
Total other liabilities	311,468		311,468			313,696
Shareholders’ equity	2,814,816		2,814,816			2,858,369
Total liabilities and shareholders’ equity	5,577,734		5,577,734			5,789,582
Operating Activities:
Net cash provided by operating activities of continuing operations			206,675	93,275
Net cash used by operating activities of discontinued operations			(115)	(2,372)
Net cash provided by operating activities			206,560	90,903
Investing Activities:
Property, plant and equipment acquired			(44,304)	(87,001)
Proceeds from sale of property, plant and equipment			4,205	2,187
Other investing activities, net			(66)	(70)
Net cash used by investing activities			(40,165)	(84,884)
Financing Activities:
Common stock issued			6,581	5,227
Excess tax (expense) benefit from share-based compensation awards			(432)	1,701
Dividends paid			(35,374)	(37,130)
Repayments of term loan			(25,000)	(25,000)
Changes in short and other long-term obligations, net			(1,262)	22,216
Treasury stock purchased			(129,504)
Net cash used by financing activities			(184,991)	(32,986)
Effect of Exchange Rate Changes on Cash and Cash Equivalents			(1,323)	(2,031)
Decrease in Cash and Cash Equivalents			(19,919)	(28,998)
Cash and Cash Equivalents at Beginning of Period			405,709	263,873
Cash and Cash Equivalents at End of Period	$ 385,790	$ 234,875	$ 385,790	$ 234,875